AFG
American Financial Group, Inc.
- Financial
- US companies in Insurance - Property & Casualty (20)
- NYSE · USD
- Mkt cap $12.5bn
$150.59
as of 26 Oct 2026, 3% below its 52-week high
Signals point to elevated dividend-cut risk, though it still screens as reasonably placed to keep growing its dividend. Its valuation looks somewhat extended against its own history.
These scores are a resilience check on the dividend, not a recommendation to buy or sell. They are not financial advice.
- Trailing yield
- 4.72%Last 12 months of regular payments at today's price
- Cash cover
- 2.5×Free cash flow over dividends paid
- Earnings cover
- 1.7×Insurers and banks set dividends from capital generation, so their accounting earnings can sit well below the payout.
- 5y dividend growth
- +12.1% a yearNo cut since FY2015
Compared with US companies in Insurance - Property & Casualty (20)
- Trailing yield is higher than 15 of the 17 other US companies in Insurance - Property & Casualty with a yield figure.
- 5y dividend growth (as paid) is higher than 12 of the 17 other US companies in Insurance - Property & Casualty with a 5y growth figure.
Quality
54
ModerateCapacity to keep growing the dividend
Risk
100
HighSignals of dividend-cut pressure
Trim
62
ModerateHow extended the valuation looks
Why Risk is 100
AFG against US companies in Insurance - Property & Casualty (20)
Valuation against its own history
As of the last reported period (30 Jun 2026). P80 means the figure is higher than 80% of AFG’s past readings.
- P/E12.2×P44, neutral for this measure
- Yield4.96%P44, neutral for this measure
- FCF payout40.3%P53, neutral for this measure
- DGR 5y-17.3%P0, poor for this measure
- ROIC9.4%P94, good for this measure
Net debt / EBITDA is left out: for banks and insurers, debt is part of the business, so the ratio says little.
Open valuation historyForecast your income with the AFG dividend calculator
Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.